Literature DB >> 7199526

Cytokinetic behavior of Ehrlich ascites tumor after in vivo treatment with cis-diamminedichloroplatinum(II) and metallocene dichlorides.

P Köpf-Maier, W Wagner, E Liss.   

Abstract

The influence of an in vivo treatment with optimally tumor-inhibiting doses of cis-diamminedichloroplatinum(II) (DDP), titanocene dichloride (TDC), and vanadocene dichloride (VDC) on the DNA distribution pattern, determined by pulse-cytophotometry, and on the mitotic activity of EAT cells is investigated. Whereas DDP causes an immediate and long-lasting decrease of mitoses but no disturbances of the EAT cell kinetics, a marked G2 block with a maximum at 10-12 h a. t. and an irreversible and extensive mitotic depression is evoked by TDC. In the case of DDP and TDC, the tumor cells are removed several days a. t. by cells belonging to the defensive system of the host animals. In contrast, VDC induces partially synchronized waves after a transient suppression of mitoses and reversible cell accumulation in the late S and in the G2 phases. Additionally, 5-16% of the cells become polyploid after VDC treatment.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7199526     DOI: 10.1007/bf00410531

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  11 in total

1.  [Molybdocene dichloride as an antitumor agent (author's transl)].

Authors:  P Köpf-Maier; M Leitner; R Voigtländer; H Köpf
Journal:  Z Naturforsch C Biosci       Date:  1979-12

2.  [Cytokinetic effect of bleomycin on mouse Ehrlich carcinoma in vivo. Possibilities of tumor cell synchronization for radiotherapy].

Authors:  J Schumann; W Göhde
Journal:  Strahlentherapie       Date:  1974-03

3.  Impulsecytophotometric studies on the effects of daunomycin on synchronised L-cells.

Authors:  W A Linden; H Baisch; L V Canstein; K König; M V Canstein
Journal:  Eur J Cancer       Date:  1974-10       Impact factor: 9.162

4.  [Synchronization of the division cycle of L cells in the G2 phase by fractioned radiation and daunomycin. Quantitative determination of the synchronization grade using the impulse cytophotometer].

Authors:  W A Linden; F Zywietz; H Landen; C Wendt
Journal:  Strahlentherapie       Date:  1973-08

5.  Tumor inhibition by titanocene dichloride: first clues to the mechanism of action.

Authors:  P Köpf-Maier; H Köpf
Journal:  Naturwissenschaften       Date:  1980-08

6.  [Tumor inhibition by metallocenes: effect of titanocene, zirconocene, and hafnocene dichlorides on Ehrlich ascites tumor in mice (author's transl)].

Authors:  P Köpf-Maier; B Hesse; H Köpf
Journal:  J Cancer Res Clin Oncol       Date:  1980-01       Impact factor: 4.553

7.  Possible mechanisms for the antitumor activity of platinum coordination complexes.

Authors:  B Rosenberg
Journal:  Cancer Chemother Rep       Date:  1975 May-Jun

8.  The interaction of an anti-tumour platinum complex with DNA.

Authors:  I A Roos
Journal:  Chem Biol Interact       Date:  1977-01       Impact factor: 5.192

9.  [Bleomycin effect on DNA replication and proliferation kinetics using Ehrlich ascites tumor as a model].

Authors:  V M Andreeff
Journal:  Arzneimittelforschung       Date:  1975-04

10.  In vitro cell growth inhibition by metallocene dichlorides.

Authors:  P Köpf-Maier; W Wagner; H Köpf
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

View more
  3 in total

1.  Development of necroses, virus activation and giant cell formation after treatment of Ehrlich ascites tumor with metallocene dichlorides.

Authors:  P Köpf-Maier
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

2.  Induction of cell arrest at G1/S and in G2 after treatment of Ehrlich ascites tumor cells with metallocene dichlorides and cis-platinum in vitro.

Authors:  P Köpf-Maier; W Wagner; E Liss
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

3.  Histologic and ultrastructural alterations of a xenografted human colon adenocarcinoma after treatment with titanocene dichloride.

Authors:  P Köpf-Maier
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.